Boston CEO
Date: Location: Cost:
May 9 - 10, 2018 Four Seasons Boston
200 Boylston Street
Boston, MA 02116
(617) 338-4400

Starting at $1950


Dress Code:
Business Attire




Time Agenda
7:30-8:30 am

Registration and Networking Breakfast

8:30-9:00 am

Welcoming Remarks -- Remembering a Biotech Legend: Henri Termeer
Christoph Westphal
Co-Founder & Partner, Longwood Fund; Rob PerezFounder & Chairman, Life Science Cares; Deborah DunsireCEO, XTuit Pharmaceuticals; Geoffrey McDonoughPresident & CEO, Swedish Orphan Biovitrum; Richard MoscickiDeputy Director, Science Operations, CDER, FDA

9:00-9:20 am

Moderated Keynote
Richard MoscickiDeputy Director, Science Operations, CDER, FDA
Moderator: Christoph WestphalCo-Founder & Partner, Longwood Fund

9:20-9:50 am

CEO Roundtable
Deborah DunsireCEO, XTuit Pharmaceuticals; Geoffrey McDonoughPresident & CEO, Swedish Orphan Biovitrum; Kabir NathPresident & CEO North America Pharmaceuticals, Otsuka America; Rob Perez, Founder & Chairman, Life Science Cares
Moderator: Pierre JacquetManaging Director, L.E.K. Consulting

9:50-10:20 am

Healthcare Market Outlook -- 2017 and Beyond
Robert GuidosAssociate Director, Legislative Affairs, CDER, FDA; Jeff LeerinkChairman & CEO, Leerink Partners; Jessica RichmanCEO, uBiome; Thilo SchroederPartnerNextech Invest; Gary ZieziulaPresident & Managing Director, EMD Serono
Moderator: Michael GoettlerGlobal President, Rare Diseases, Pfizer

10:20-10:50 am

Networking Break

10:50-11:20 am

Understanding and Managing Growth
Mary Lynne HedleyCo-Founder, President & COO, TESARO; William HeidenCEO, AMAG Pharmaceuticals; Sanjiv PatelCEO, Relay Therapeutics; Shalini SharpCFO, Ultragenyx; Timothy WrightEVP, Strategy, BD, & Innovation, Teva
Moderator: Robert BeardsleyCOO, Galera Therapeutics

11:20-11:50 am

Diversity: Moving from Sound Bite to Implementation
Jeff AlbersCEO, Blueprint Medicines; Suzanne BruhnPresident & CEO, Proclara Biosciences; Amri JohnsonGlobal Head, Diversity & Inclusion, Novartis Institutes for BioMedical Research; Helen TorleyPresident & CEO, Halozyme Therapeutics
Moderator: Cissy YoungExecutive Director, Russell Reynolds

11:50-12:20 pm

Ensuring Transparency and Drug Value
Melissa Bradford-KlugCBO, Keryx; Thomas Lönngrenformer Executive Director, European Medicines Agency; Ed MascioliCEO, Karos Pharmaceuticals; Gilmore O'NeillSVP, Late Stage Clinical Development, Biogen
Moderator: Ron CooperPresident & CEO, Albireo

12:20-1:20 pm

Networking Lunch

1:20-1:50 pm

Accessing Early-Stage Innovation
Ansbert GadickeCo-Founder & Managing Director, MPM Capital; Arthur Krieg, CEO & Founder, Checkmate Pharmaceuticals; Brian McVeighVP, WWBD Transactions & Investment Management, GlaxoSmithKline; Chandra RamanathanHead, East Coast Innovation Center, Bayer; Ken RhodesCSO, Yumanity
Moderator: Adi HoessCEO, Affimed

1:50-2:20 pm

Therapeutic Market Focus: Microbiome
Rodolphe ClervalCBO, Enterome; Bernat OlleCEO, Vedanta Biosciences; Jeff RileyCEO, Synthetic Biologics; Michele TrucksisCMO, Seres Therapeutics
Moderator: Todd KruegerPresident, AOBiome

2:20-2:50 pm

Oncology Trends and Predictions
Gil BeyenChairman & CEO, Erytech; Roman FleckCEO, Janpix; Jimmy LinCSO, Natera; Oliver RosenCMO, Deciphera; Patrick TricoliCEO, Nanobiotix US
Moderator: Jeremy GoldbergManaging Director, Torreya Partners

2:50-3:20 pm

Networking Break

3:20-3:50 pm

Building a Biotech: Innovative Business Models
JC Gutierrez-RamosCEO, Synlogic Therapeutics; Ana MaiquesCEO, Neuroelectrics; Eddie MartucciCo-Founder & CEO, Akili Interactive; Paula SoteropoulosCEO, Akcea Therapeutics; Gregory VerdineFounder, CEO, & CSO, FogPharma
Moderator: Yuval CohenCEO, Corbus Pharmaceuticals

3:50-4:20 pm

Partner or Go it Alone?
Sharon ClarkeCBO, JDP Therapeutics; Kia MoteshareiGlobal Head, BD, Neurology & Immunology, EMD Serono; Tim NoyesPresident & CEO, Proteon Therapeutics; Mark NuttallHead, MS & Immunology BD&L, Sanofi Genzyme
Moderator: Chris CaseyGlobal Head, Key Accounts & Services, Commercial, inVentiv Health

4:20-4:50 pm

Next Generation Biotech CEOs and Board Members
Nessan BerminghamPresident & CEO, Intellia Therapeutics; Nancy LurkerPresident & CEO, pSivida; Francois NaderChairman, Acceleron Pharma; Matt RodenVP, Strategic Corporate Development, Bristol-Myers Squibb; Leslie Williams, Founder, President & CEO, ImmusanT
Moderator: Robert ForresterPresident & CEO, Verastem

4:50-6:00 pm

Cocktails and Hors d'oeuvres

MAY 31, 2017


Time Agenda
7:30-8:30 am

Registration and Networking Breakfast

8:30-8:40 am

Welcome and Opening Remarks
Roger Tung
CEO, Concert Pharmaceuticals; Sue WasherPresident & CEO, AGTC; Steve CutlerCEO, ICON; Al SandrockCMO & EVP, Biogen

8:40-9:10 am

Advances in Personalized Medicine
Arthur HillerCEO, Antyllus; Kenneth Moch, President & CEO, Cognition Therapeutics; Joe PaynePresident & CEO, Arcturus; Steven PerrinCEO & CSO, ALS Therapy Development Institute; Al SandrockCMO & EVP, Biogen
Moderator: Robert SilvermanHead, Externalized Drug Discovery PartneringRoche

9:10-9:40 am

Small-Cap and Private Biotech: Leveraging Potential
Frederick Beddingfield
President & CEO, Sienna Biopharmaceuticals; Alan EzekowitzCEO, Abide Therapeutics; Brian LeuthnerPresident & CEO, Edge Therapeutics; Dan SwisherCEO, Sunesis Pharmaceuticals; Ailis Tweed-KentFounder & CEO, Cocoon Biotech
Moderator: Gregg BeloffCFO, Centrexion Therapeutics

9:40-10:10 am

Therapeutic Market Focus: Cell & Gene Therapy
Al Gianchetti
CEO, XyloCor Therapeutics; Michael JirousekCOO, Frequency Therapeutics; Jak KnowlesPresident & CEO, Exonics Therapeutics; Sam RastyCOO, Homology Medicines; Amber SalzmanPresident & CEO, Adverum Biotechnologies
Moderator: Pascal TouchonSVP, Global Head Strategy & BD&L, Novartis

10:10-10:40 am

Networking Break

10:40-11:00 am

Fireside Chat
Michael Ehlers
EVP, R&D, Biogen; David MeekCEO, IPSEN
Moderator: Christoph WestphalCo-Founder & Partner, Longwood Fund

11:00-11:30 am

Accessing Innovation via M&A and Partnerships
Sven DethlefsGlobal Head Respiratory Medicines, Teva; Elcin Ergun BarkerPresident, New Business, EMD Serono; Jeff JonkerPresident, NGM Bio; Cynthia Schwalm, President, North America Commercial Operations, IPSEN; Malcolm WeirCEO, Heptares
Moderator: Sue WasherPresident & CEO, AGTC

11:30-12:00 pm

Buy or Build?
Danguole AltmanPresident & CEO, Vapogenix; Grace ColonCEO, InCarda Therapeutics; John CoxCEO, Bioverativ; Roger TungCEO, Concert Pharmaceuticals
Moderator: Steve CutlerCEO, ICON

12:00-1:00 pm

Networking Lunch

1:00-1:30 pm

Evolving BioPharma Boards
James GeraghtyChairman, Juniper Pharma; Quang PhamFounder, Chairman & CEO, Espero Pharmaceuticals; Ronald RenaudCEO, RaNA Therapeutics; David Southwell, President & CEO, Inotek Pharmaceuticals
Moderator: Don deBethizyChairman, Albumedix A/S

1:30-2:00 pm

Boston-Bound Biotech and Pharma: Impact on Innovation
Paul BiondiSVP, Head, BD, Bristol-Myers Squibb; Paul BolnoPresident & CEO, WAVE Life Sciences; Chris GarabedianChairman & CEO, Xontogeny; Ole IsacsonFounder, NyaCell; Jonathan LewisCEO, Samus Therapeutics
Moderator: Robert CoughlinPresident & CEOMassBio

2:00-2:30 pm

Global Markets: Biotechs Across Borders
Carolina Alarco
, President, Global Marketing & International Markets, Aegerion; Samantha DuChairperson & CEO, Zai Laboratory; Mark RotheraCCO, PTC Therapeutics; James XueCEO, CANbridge Life Sciences
Moderator: Mary SzelaCEO, Novelion Therapeutics

2:30-3:00 pm

Networking Break

3:00-3:20 pm

Fireside Chat
Robert Coughlin
President & CEO, MassBio; John MaraganoreCEO, Alnylam
Moderator: Christoph WestphalCo-Founder & Partner, Longwood Fund

3:20-3:50 pm

Achieving Organizational Turnarounds
Richard Daly
Chairman & CEO, Neuralstem; Ed KayeCEO, Sarepta; Sandy MacraeCEO, Sangamo Therapeutics; Adelene PerkinsChairman & CEO, Infinity Pharmaceuticals
Moderator: Hugh ColeCBO, ARIAD

3:50-4:20 pm

M&A Activity Post the IPO-Boom: Impact on Fundraising and Dealmaking
Luc Dochez, CEO, Tusk Therapeutics; Luba GreenwoodVP, Global BD & M&A, Roche; John HaurumCEO, F-star Biotechnology; Jim HealyManaging General Partner, Sofinnova Ventures
Moderator: Philippe Lopes-FernandesSVP, Global Head, BD & Alliance ManagementEMD Serono

4:20-4:30 pm

Presentation of 2017 Boston CEO Lifetime Achievement Award
Robert Coughlin, 2016 Honoree; John Maraganore, 2015 Honoree

4:30-5:30 pm

Cocktails and Hors d'oeuvres

Executive Sponsors: (see all sponsors)